Analystreport

Bristol-Myers Squibb (NYSE: BMY) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $50.00 price target on the stock.

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html